Cargando…
Synergy effects of Asperosaponin VI and bioactive factor BMP-2 on osteogenesis and anti-osteoclastogenesis
Osteoporosis is a reduction in skeletal mass due to the decrease of osteogenic ability and the activation of the osteoclastic function. Inhibiting bone resorption and accelerating the new bone formation is a promising strategy to repair the bone defect of osteoporosis. In this study, we first system...
Autores principales: | Chen, Fangping, Liang, Qing, Mao, Lijie, Yin, Yanrong, Zhang, Lixin, Li, Cuidi, Liu, Changsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636809/ https://www.ncbi.nlm.nih.gov/pubmed/34901550 http://dx.doi.org/10.1016/j.bioactmat.2021.09.001 |
Ejemplares similares
-
Therapeutic effects of asperosaponin VI in rabbit tendon disease
por: Wang, Kun, et al.
Publicado: (2022) -
Asperosaponin VI Injection Enhances Orthodontic Tooth Movement in Rats
por: Ma, Dan, et al.
Publicado: (2020) -
Asperosaponin VI stimulates osteogenic differentiation of rat adipose-derived stem cells
por: Ding, Xingpo, et al.
Publicado: (2019) -
Research on the Mechanism of Asperosaponin VI for Treating Recurrent Spontaneous Abortion by Bioinformatics Analysis and Experimental Validation
por: Xia, Bo, et al.
Publicado: (2022) -
Osteoclastogenesis and Osteogenesis
por: Kim, Jung-Eun
Publicado: (2022)